Jiandong Xu

Insider Reports History

Entity
Individual
Location
C/O Denali Capital Acquisition Corp., 437 Madison Avenue, 27 Th Floor, New York, NY
Signature
/s/ Jiandong Xu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jiandong Xu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Denali Capital Acquisition Corp. 10%+ Owner Class B Ordinary Shares 1.43M Aug 30, 2024 Indirect
Estrella Immunopharma, Inc. Chief Financial Officer Common Stock 264K Sep 29, 2023 Direct

Insider Reports Filed by Jiandong Xu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DECA Denali Capital Acquisition Corp. Aug 30, 2024 1 $0 4 Sep 16, 2024 10%+ Owner
UPTD Estrella Immunopharma, Inc. Sep 29, 2023 0 $0 3 Oct 10, 2023 Chief Financial Officer
DECA Denali Capital Acquisition Corp. May 21, 2022 1 $0 4 May 24, 2022 10%+ Owner
DECA Denali Capital Acquisition Corp. Apr 11, 2022 1 $5.1M 4 Apr 13, 2022 10%+ Owner
DECA Denali Capital Acquisition Corp. Apr 6, 2022 0 $0 3 Apr 6, 2022 10%+ Owner